Recurrent endometrial cancer occurs when cancer that started in the lining of the uterus returns after treatment, sometimes months or even years later. While facing a cancer recurrence can bring anxiety and uncertainty, understanding what happens and what options exist can help patients and their families navigate this challenging journey with more confidence.

What Is Recurrent Endometrial Cancer?

Endometrial cancer begins in the endometrium, which is the inner lining of the uterus. It stands as the most common gynecologic cancer in the United States. When someone finishes treatment for endometrial cancer and shows no signs of the disease in their body, doctors say they are in remission. Unfortunately, even after successful treatment, the cancer can return. This return is called recurrent endometrial cancer.^[1]

Recurrent endometrial cancer can appear in two main ways. A local recurrence means the cancer has come back in or near the original location, most commonly in the pelvis or vagina. In fact, the cancer most often returns at the vaginal cuff, which is the top of the vagina where it was connected to the uterus before surgery.^[1] The second type is distant recurrence, where the cancer reappears in other parts of the body such as the lungs or bones. Some people experience both local and distant recurrences at the same time.^[1]

When cancer spreads to distant areas, it may also be called metastatic cancer. When distant recurrence happens in just a few specific spots without evidence of cancer elsewhere in the body, doctors use the term isolated metastases. If the cancer returns in many locations throughout the body, it is referred to as disseminated disease.^[5]

Epidemiology: How Common Is Recurrence?

After initial treatment, between 15% and 20% of people with early-stage endometrial cancer—that is, stage I or stage II—will experience a recurrence. Among those who do have a recurrence, approximately 50% will have a local recurrence, 25% will have a distant recurrence, and 25% will have both types.^[1]

The timing of recurrence follows a pattern. Most recurrences happen within the first three years after initial treatment. This means that the first few years after completing therapy are a critical period for monitoring and follow-up care.^[1][2]

Even after a hysterectomy—surgery to remove the uterus and cervix—cancer can still return. About 15% to 20% of people who have endometrial cancer experience a recurrence after having their uterus removed. The cancer can recur anywhere in the body, but it appears most commonly at the vaginal cuff.^[1]

Causes: Why Does Endometrial Cancer Return?

The reasons why endometrial cancer returns after treatment are complex. Cancer cells are sometimes able to survive initial treatments, remaining hidden in the body at levels too small to detect with current medical technology. Over time, these surviving cells can grow and multiply, leading to a recurrence. The biology of the cancer cells themselves plays a major role in whether they can withstand treatment and regrow later.

The type of endometrial cancer matters significantly. Endometrial cancer is classified into two main types. Type 1 endometrial cancers are linked to high levels of the hormone estrogen and tend to be less aggressive. Studies show that around 20% of type 1 cases recur. Type 2 cancers, which include clear cell and serous carcinomas, do not rely on estrogen, tend to grow faster, and behave more aggressively. Approximately half of type 2 endometrial cancer cases recur.^[2]

Genetic changes within cancer cells also contribute to recurrence. For example, cancers with a gene mutation like TP53 tend to be more aggressive and have a higher likelihood of returning after treatment.^[1] These genetic alterations can make cancer cells more resistant to treatments or better able to evade the body’s immune system.

Risk Factors: Who Is More Likely to Experience Recurrence?

Several factors increase the risk that endometrial cancer will come back after treatment. Understanding these risk factors can help patients and doctors plan more appropriate follow-up care and surveillance.

One major risk factor is having late-stage cancer at the time of original diagnosis. The more advanced the cancer, the more likely it is to recur. Similarly, if the cancer has spread to lymph nodes—small bean-shaped structures that are part of the immune system—the risk of recurrence increases.^[1]

Tumor size matters as well. Tumors larger than 2 centimeters, which is about the size of a grape, have a higher chance of recurring compared to smaller tumors.^[2]

Tumor grade is another important consideration. This term describes how cancer cells look under a microscope. Low-grade tumors resemble normal cells and are less likely to spread or return. High-grade tumors look more abnormal, behave more aggressively, and are more likely to come back after treatment.^[2]

Myometrial invasion refers to how deeply the cancer has penetrated into the myometrium, which is the muscular wall of the uterus. Cancer that invades deeply into this area is more likely to come back, especially if the cancer cells are more aggressive. Research has found that the risk of recurrence becomes about twice as high when cancer spreads deeply into the myometrium.^[2]

Timing of surgery also plays a role. If someone waits six months or more after the initial biopsy to have a hysterectomy, the risk of recurrence increases. Additionally, if during hysterectomy the surgeon did not remove the fallopian tubes, ovaries, and cervix in a procedure called bilateral salpingo-oophorectomy, the recurrence risk may be higher.^[1]

It is important to note that not everyone with these risk factors will experience a recurrence. Many other factors influence individual risk. Conversely, even people without any of these known risk factors can still have their cancer return.^[1]

Symptoms: What to Watch For

After completing treatment for endometrial cancer, patients should remain alert to certain symptoms that could signal the cancer has returned. Recognizing these symptoms early allows for prompt medical evaluation and, if necessary, treatment.

One common symptom of recurrent endometrial cancer is bleeding from the vagina. Any new or unusual vaginal bleeding after treatment should be reported to a doctor immediately.^[1]

Changes in bladder or bowel habits can also be warning signs. This might include difficulty urinating, increased frequency of urination, constipation, diarrhea, or other changes in how the bladder or bowels function.^[1]

Pain in the belly or back is another symptom to watch for. This pain may be persistent or come and go, and it should not be ignored, especially if it develops after a period of feeling well following treatment.^[1]

General symptoms such as tiredness, bloating, shortness of breath, nausea, or vomiting can also occur with recurrent endometrial cancer. While these symptoms can have many causes, they warrant medical attention when they persist or worsen, particularly in someone with a history of endometrial cancer.^[1]

Because of the possibility of recurrence, doctors recommend regular follow-up visits. Typically, an oncologist—a doctor who specializes in cancer treatment—will check patients every three to six months for the first three years after treatment. These visits aim to catch any recurrence as early as possible. Between scheduled visits, patients should contact their healthcare team if they notice any concerning symptoms.^[1]

Prevention: Reducing Recurrence Risk

While it is not always possible to prevent endometrial cancer from recurring, certain steps may help reduce the risk or catch recurrence at an earlier, more treatable stage.

Regular follow-up care is essential. This includes attending all scheduled appointments with the oncology team, even when feeling well. These appointments typically involve physical examinations, pelvic exams, and sometimes imaging tests to look for any signs that cancer has returned. Following the recommended surveillance schedule gives doctors the best chance to detect recurrence early.^[6]

Maintaining a healthy lifestyle may also play a role. This includes eating a balanced diet, staying physically active as recommended by healthcare providers, maintaining a healthy weight, and avoiding tobacco products. While these measures cannot guarantee prevention of recurrence, they support overall health and may improve treatment outcomes if cancer does return.^[1]

For some patients, depending on their initial cancer characteristics and treatment, doctors may recommend ongoing treatments after the primary therapy is complete. This might include hormone therapy or other medications designed to reduce the risk of recurrence. Patients should discuss with their healthcare team whether any additional preventive measures are appropriate for their specific situation.^[5]

Pathophysiology: What Happens in the Body

Understanding what happens in the body when endometrial cancer recurs involves looking at how cancer cells behave and how the body’s normal functions are disrupted.

When endometrial cancer first develops, abnormal cells in the endometrium begin to grow uncontrollably. Initial treatment aims to remove or destroy these cancer cells through surgery, radiation, chemotherapy, or a combination of approaches. However, sometimes a small number of cancer cells survive treatment. These surviving cells may remain dormant for months or years, too few in number to be detected by medical tests.

Over time, these hidden cancer cells can begin to multiply again. They may remain in the area where the cancer originally started, leading to local recurrence. Alternatively, cancer cells may have spread through the lymphatic system or bloodstream to other parts of the body before or during initial treatment. When these distant cells begin growing, they cause distant recurrence or metastases.

The behavior of cancer cells is influenced by their genetic makeup. Some cancer cells carry mutations that make them particularly aggressive or resistant to treatment. For instance, cancers with certain gene changes, such as TP53 mutations, tend to grow faster and are more likely to recur.^[1]

In type 1 endometrial cancers, the hormone estrogen plays a significant role in cancer cell growth. These cancers have receptors on their surface that respond to estrogen, which can stimulate cell division. Type 2 cancers do not depend on estrogen and tend to grow more aggressively through other biological pathways.^[2]

When cancer recurs locally in the pelvis or vagina, it can cause symptoms by pressing on nearby organs or tissues. For example, a tumor growing near the bladder might cause urinary symptoms, while one near the rectum might affect bowel function. Distant metastases in organs like the lungs can interfere with breathing, while those in bones can cause pain.^[1]

The body’s immune system normally works to identify and destroy abnormal cells, including cancer cells. However, cancer cells can sometimes evade immune detection or suppress immune responses, allowing them to survive and grow. This complex interaction between cancer cells and the immune system influences whether and when a recurrence might occur.

Recent research has focused on understanding these biological mechanisms more deeply. Scientists are studying how cancer cells develop resistance to treatment, how they spread through the body, and what makes some cancers more likely to recur than others. This knowledge is leading to the development of new targeted therapies and immunotherapies that may be more effective at preventing or treating recurrent endometrial cancer.^[7]